Form 4 for STLN Starling Oncology, Inc.
Accepted 2026-05-20 12:25:29 ET · period of report 2026-05-19 · accession 0000921895-26-001444 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-20 12:25 | 2026-05-19 | STLN | Chernett Jorey | 10% | P - Purchase | $4.09 | +30.0K | 10.53M | +0.3% | +$122.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-19 | P | A | 30,000 | $4.09 | 10,529,358 | D | — | — |